Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
JAK3 Inhibitor VII, AD412
Cat No.
CEI-1068
Description
A cell-permeable indole-3-propanamide immunosuppressant that is shown to selectively inhibit the kinase activity of JAK3 (by 81% and 36% at 90 and 30 µM, respectively) over that of JAK2 (by 29% and 0% at 90 and 30 µM, respectively) and reduce JAK1/3-dependent phosphorylations of Akt, STAT5a/b, and Erk1/2 in IL-2-stimulated CTL-L2 cells, but not JAK1/2-dependent STAT1 phosphorylation in INF-γ-stimulated U266 cultures. Reported to inhibit ConA-stimulated murine splenocytes and PHA-stimulated human PBL proliferation (IC50 = 17 and 25 µM, respectively) in vitro and be efficacious in ameliorating delayed hypersensitivity reaction in mice (by ~78% with a daily oral dose of 50 mg/kg) and in prolonging the survival of heart transplant-recipient rats (by >3-fold with 60 mg/kg/day, p.o.) in vivo.
Abbr
JAK3 Inhibitor VII, AD412(JAK3)
Alias
JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK
CAS No.
796041-65-1
Molecular Weight
389.9
Purity
>95% by HPLC
Storage
+2 centigrade to +8 centigrade
Synonyms
JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK
Targets
JAK3
Molecular Formula
C23H20ClN3O
Chemical Name
N-(Pyridin-4-yl)-3-[1-(4-chlorobenzyl)indol-3-yl]-propanamide
Solubility
DMSO
Download
Download Datasheet